Quantcast

Latest Dronedarone Stories

2014-05-20 08:32:11

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, May 20, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Gilead Sciences, Inc. (NASDAQ: GILD), Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR), Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) and Puma Biotechnology, Inc. (NYSE: PBYI). Private wealth members receive these notes ahead of publication. To reserve...

2012-04-26 23:01:58

On April 15th 2012, the Financial Times reported that Sanofi´s drug Multaq lost reimbursement in France and faced new restrictions in other countries. Multaq (Dronedarone) is a drug manufactured by Sanofi and used by patients who had recently experienced heart issues like atrial fibrillation (a type of abnormal heart rhythm) or atrial flutters. It was approved by the FDA in 2009. In January 2011, the FDA issued a warning about cases of rare, but severe liver injury, including two cases...

2012-02-28 10:35:00

An irregular heartbeat – atrial fibrillation – is a strong predictor of cognitive decline and the loss of independence in daily activities in older people at risk of cardiovascular disease, according to a study in CMAJ (Canadian Medical Association Journal). Researchers sought to understand whether there was an association between an irregular heartbeat and the loss of mental and physical functions in people at risk of cardiovascular disease. They looked at data from two...

2011-06-27 15:00:00

LA JOLLA, Calif., June 27, 2011 /PRNewswire/ -- Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, announces that the data from its completed Phase 2 CUPID clinical study of MYDICAR® for the treatment of advanced heart failure is being published today online in Circulation, an American Heart Association journal. "I am very encouraged that our approach of restoring a critical enzyme...

2011-05-23 09:00:00

SEATTLE, Wash., May 23, 2011 /PRNewswire/ -- Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, today announced that 18-month data from its Phase 2 CUPID clinical trial of MYDICAR® demonstrated continued improvements in clinical outcomes in advanced heart failure patients treated with the genetically-targeted enzyme replacement therapy. "We are pleased to present data from the...

2011-05-04 19:26:22

Lead investigator available at HeartRhythm 2011 to discuss data that underscore the growing impact of AFib on US health care costs and resources Two studies to be presented this week address the often-overlooked costs associated with atrial fibrillation (AFib), the most common form of cardiac arrhythmia. Each study evaluates these costs and updates a growing body of evidence suggesting that the true costs of AFib are complex and may not yet be fully understood. The patient populations studied...

2011-02-18 08:08:51

(Ivanhoe Newswire) "“ Use of an implanted device to monitor the condition of heart failure patients reduces the rate of hospitalization by 39 percent, according to this study. These findings also indicate a low device failure rate, suggesting that the devices can be safely used and therefore significantly reduce the cost of care. The implanted device works by measuring the pressures within the pulmonary arteries (those connecting the heart to the lungs). In the study, patients with...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related